PDK1 is a critical component of the oncogenic phosphoinositide 3‐kinase signalling and its overexpression has been documented in breast cancer 37, acute myeloid leukaemia 38 and multiple myeloma 39. This evidence concerns the gene PDK1 and AL amyloidosis.